These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17109975)

  • 61. Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma.
    Hart GJ; Orr DC; Penn CR; Figueiredo HT; Gray NM; Boehme RE; Cameron JM
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1688-94. PubMed ID: 1384425
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance.
    Kerr SG; Anderson KS
    Biochemistry; 1997 Nov; 36(46):14064-70. PubMed ID: 9369478
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel HIV-1 reverse transcriptase inhibitors.
    Jochmans D
    Virus Res; 2008 Jun; 134(1-2):171-85. PubMed ID: 18308412
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
    Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
    EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Deoxythioguanosine triphosphate impairs HIV replication: a new mechanism for an old drug.
    Krynetskaia NF; Feng JY; Krynetski EY; Garcia JV; Panetta JC; Anderson KS; Evans WE
    FASEB J; 2001 Sep; 15(11):1902-8. PubMed ID: 11532970
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
    Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine.
    Suzuki K; Kaufmann GR; Mukaide M; Cunningham P; Harris C; Leas L; Kondo M; Imai M; Pett SL; Finlayson R; Zaunders J; Kelleher A; Cooper DA
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1293-6. PubMed ID: 11559430
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine.
    Paolucci S; Baldanti F; Campanini G; Cancio R; Belfiore A; Maga G; Gerna G
    Antiviral Res; 2007 Nov; 76(2):99-103. PubMed ID: 17640745
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The nucleoside analogue D-carba T blocks HIV-1 reverse transcription.
    Boyer PL; Vu BC; Ambrose Z; Julias JG; Warnecke S; Liao C; Meier C; Marquez VE; Hughes SH
    J Med Chem; 2009 Sep; 52(17):5356-64. PubMed ID: 19678643
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E.
    Althaus IW; Chou JJ; Gonzales AJ; Deibel MR; Chou KC; Kezdy FJ; Romero DL; Aristoff PA; Tarpley WG; Reusser F
    J Biol Chem; 1993 Mar; 268(9):6119-24. PubMed ID: 7681060
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Potential multifunctional inhibitors of HIV-1 reverse transcriptase. Novel [AZT]-[TSAO-T] and [d4T]-[TSAO-T] heterodimers modified in the linker and in the dideoxynucleoside region.
    Velázquez S; Tuñón V; Jimeno ML; Chamorro C; De Clercq E; Balzarini J; Camarasa MJ
    J Med Chem; 1999 Dec; 42(25):5188-96. PubMed ID: 10602704
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efavirenz accelerates HIV-1 reverse transcriptase ribonuclease H cleavage, leading to diminished zidovudine excision.
    Radzio J; Sluis-Cremer N
    Mol Pharmacol; 2008 Feb; 73(2):601-6. PubMed ID: 18024510
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel 4'-substituted stavudine analog with improved anti-human immunodeficiency virus activity and decreased cytotoxicity.
    Dutschman GE; Grill SP; Gullen EA; Haraguchi K; Takeda S; Tanaka H; Baba M; Cheng YC
    Antimicrob Agents Chemother; 2004 May; 48(5):1640-6. PubMed ID: 15105115
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 4'-Ethynyl-2-fluoro-2'-deoxyadenosine, MK-8591: a novel HIV-1 reverse transcriptase translocation inhibitor.
    Markowitz M; Sarafianos SG
    Curr Opin HIV AIDS; 2018 Jul; 13(4):294-299. PubMed ID: 29697468
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of New DNA Aptamers for Anti-HIV-1 Reverse Transcriptase.
    Ratanabunyong S; Aeksiri N; Yanaka S; Yagi-Utsumi M; Kato K; Choowongkomon K; Hannongbua S
    Chembiochem; 2021 Mar; 22(5):915-923. PubMed ID: 33095511
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The valine-to-threonine 75 substitution in human immunodeficiency virus type 1 reverse transcriptase and its relation with stavudine resistance.
    Selmi B; Boretto J; Navarro JM; Sire J; Longhi S; Guerreiro C; Mulard L; Sarfati S; Canard B
    J Biol Chem; 2001 Apr; 276(17):13965-74. PubMed ID: 11134027
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structural dynamics and susceptibility of anti-HIV drugs against HBV reverse transcriptase.
    Kammarabutr J; Mahalapbutr P; Okumura H; Wolschann P; Rungrotmongkol T
    J Biomol Struct Dyn; 2021 Apr; 39(7):2502-2511. PubMed ID: 32308149
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Probing the molecular mechanism of action of the HIV-1 reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) using pre-steady-state kinetics.
    Muftuoglu Y; Sohl CD; Mislak AC; Mitsuya H; Sarafianos SG; Anderson KS
    Antiviral Res; 2014 Jun; 106():1-4. PubMed ID: 24632447
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Triphosphate Prodrugs of the Anti-HIV-Active Compound 3'-Deoxy-3'-fluorothymidine (FLT).
    Weising S; Weber S; Schols D; Meier C
    J Med Chem; 2022 Sep; 65(18):12163-12175. PubMed ID: 36099330
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs.
    Feng JY; Johnson AA; Johnson KA; Anderson KS
    J Biol Chem; 2001 Jun; 276(26):23832-7. PubMed ID: 11328813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.